Table 5. Secondary outcomes during hospitalization among children and adults with acute dengue in Southern Province, Sri Lanka, 2017–2018.
| Children <18 years (n = 70) | Adults ≥18 years (n = 994) | Overall (n = 1064) | |
|---|---|---|---|
| Number (percentage) or median (IQR) | Number (percentage) or median (IQR) | Number (percentage) or median (IQR) | |
| Crystalloid bolus use | 23 (32.8) | 425 (42.8) | 448 (42.1) |
| Colloid use | 3 (4.3) | 59 (5.9) | 62 (5.8) |
| Blood transfusion | 1 (1.4) | 17 (1.7) | 18 (1.7) |
| Platelet transfusion | 0 | 5 (0.5) | 5 (0.5) |
| Fresh frozen plasma transfusion | 0 | 4 (0.4) | 4 (0.4) |
| Tranexamic use | 8 (11.4) | 201 (20.2) | 209 (19.6) |
| Steroid use | 2 (2.8) | 4 (0.4) | 6 (0.6) |
| Vasopressor use | 0 | 5 (0.5) | 5 (0.5) |
| Acute renal failure requiring dialysis | 0 | 4 (0.4) | 4 (0.4) |
| Intensive care unit transfer | 1 (1.4) | 16 (1.6) | 17 (1.6) |
| Hospitalization duration (days) | 4 (3–5) | 4 (3–5) | 4 (3–5) |
| Death | 0 | 2 (0.2) | 2 (0.2) |
1AST is aspartate transaminase and ALT is alanine transaminase.